Not yet recruiting NCT06443528
Comparison of Lung Ultrasound Scores With Clinical Models for Predicting Bronchopulmonary Dysplasia：A Multi-center Prospective Cohort Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: lung ultrasound.
- Who it may be relevant to
- Registry conditions: Lung Ultrasound, Bronchopulmonary Dysplasia. Basic parameters: 0 Weeks — 32 Weeks · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aimed to fill this knowledge gap and designed a multicentre cohort study to verify the hypothesis that LUS has good reliability to predict BPD in China and to compare the predictive value of LUS and clinical models for the development of BPD at different time points in infants born before and after 28 weeks.
Interventions
- Diagnostic test lung ultrasound
All enrolled infants underwent LUS examination performed by two ultrasound physicians. Monitoring included a complete lung scan in the first 24 hours of life (T0) and at day 3 (T1). All neonates underwent weekly ultrasound examinations until 36 weeks postmenstrual age (T2, T3…), so that the T2 scan was carried out at the end of the first week of life. LUS was performed according to a standardized protocol \[13\] when the neonate was in a quiet state, during routine clinical care to minimise disc
Primary outcome measures
- bronchopulmonary dysplasia [Time frame: 2024.06.01-2027.06.30]
Eligibility criteria
Inclusion criteria
- Preterm infants with GA <32 weeks.
- Infants with enrollment within 24 hours from birth
- Parental written consent is obtained.
Exclusion criteria
- Complex congenital malformations or chromosomal abnormalities
- Congenital lung diseases or congenital heart defects
- Infants with enrollment after 24 hours from birth
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06443528 · jddyyy